RNA quantitation is becoming increasingly important in basic. pharmaceutica
l, and clinical research. For example, quantitation of viral RNAs can predi
ct disease progression and therapeutic efficacy(1). Likewise. gene expressi
on analysis of diseased versus normal, or untreated versus treated, tissue
can identify relevant biological responses or assess the effects of pharmac
ological agents(2). As the focus of the Human Genome Project moves toward g
ene expression analysis, the field will require a flexible RNA analysis tec
hnology that can quantitatively monitor multiple forms of alternatively tra
nscribed and/or processed RNAs (refs 3,4). We have applied the principles o
f invasive cleavage(5) and engineered an improved 5'-nuclease to develop an
isothermal, fluorescence resonance energy transfer (FRET)-based(6) signal
amplification method for detecting RNA in both total RNA and cell lysate sa
mples. This detection format, termed the RNA invasive cleavage assay, obvia
tes the need for target amplification or additional enzymatic signal enhanc
ement(7). In this report, we describe the assay and present data demonstrat
ing its capabilities for sensitive (<100 copies per reaction), specific (di
scrimination of 95% homologous sequences, 1 in <greater than or equal to>20
,000), and quantitative (1.2-fold changes in RNA levels) detection of unamp
lified RNA in both single- and biplex-reaction formats.